Company Reports Q1 Revenue of $3.61B
Reports Q1 revenue $3.61B, consensus $3.39B. "We are pleased with the Company's first quarter results, which reflect the team's commitment to patients as well as the operating and growth priorities discussed at the Investor Day in March," said CEO Jon Rousseau. "Our focus continues to be anchored in operational and commercial best practices across the organization while leveraging scale to provide quality and effective services to complex patient populations. As we look ahead to the remainder of 2026, we are focused on growing each of our businesses while executing against our goals and reaching more patients who can benefit from these highly impactful and valuable services."
